Validation of Predictors of OAC Initiation Using EMR Data

NCT03006341 · clinicaltrials.gov ↗

COMPLETED

Status

140187

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Dabigatran etexilate
DRUG: Warfarin

Sponsor

Boehringer Ingelheim